Reflections on Communication Difficulties Related to Covid-19
Keywords:covid-19, communication difficulties, uncertainty, laypeople explanations
This paper describes some of the concept which are often miscommunicated between scientists, politicians and laypeople. Scientists are advised to take a more active role in explaining relevant concepts so that they can be understood by laypeople and thus facilitate better discussions.
Cambridge Dictionary (accessed June 5th 2021 - https://dictionary.cambridge.org/dictionary/english/evidence-based
Our World Data website (accessed June 7th 2021 - https://ourworldindata.org/life-expectancy-how-is-it-calculated-and-how-should-it-be-interpreted
Swedish Radio March 4th 2021 quoting Statistics Sweden - https://sverigesradio.se/artikel/covid-19-sanker-livslangden-och-hojer-pensionen
News from Danish Broadcasting Corporation. May 6th 2020 - https://www.dr.dk/nyheder/indland/ny-kritik-af-corona-beregninger-moerketal-kan-vaere-meget-mindre
Ekelund SL: False Covid-19 Test Results – Could We Do Things Better? A Personal Opinion. Asian Journal of Pharmacy, Nursing and Medical Sciences, 2020; 8(5). https://doi.org/10.24203/ajpnms.v8i5.6349
Reuters March 16th 2020 - https://www.reuters.com/article/us-healthcare-coronavirus-who-idUSKBN2132S4
Rode DC, Fischbeck PS. On Ambiguity Reduction and the Role of Decision Analysis during the Pandemic. Risk Analysis, 2021; 41(5): 721-730. DOI: 10.1111/risa.13705
Nasserie T, Hittle M, Goodman SN. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review. JAMA Netw Open. 2021 May 3; 4(5): e2111417. doi: 10.1001/jamanetworkopen.2021.11417
Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments.
Infect Dis (Lond). 2021 May 22:1-18. doi: 10.1080/23744235.2021.1924397
WHO website. The different types of COVID-19 vaccines. https://www.who.int/news-room/feature-stories/detail/the-race-for-a-covid-19-vaccine-explained
European Medicines Agency website. Conditional marketing authorization. (Accessed June 14th 2021 - https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/conditional-marketing-authorisation
FDA website. Emergency Use Authorization for Vaccines Explained. (Accessed June 14th 2021 - https://www.fda.gov/vaccines-blood-biologics/vaccines/emergency-use-authorization-vaccines-explained
How to Cite
Copyright (c) 2021 Suzanne Lisbeth Ekelund
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
- Papers must be submitted on the understanding that they have not been published elsewhere (except in the form of an abstract or as part of a published lecture, review, or thesis) and are not currently under consideration by another journal published by any other publisher.
- It is also the authors responsibility to ensure that the articles emanating from a particular source are submitted with the necessary approval.
- The authors warrant that the paper is original and that he/she is the author of the paper, except for material that is clearly identified as to its original source, with permission notices from the copyright owners where required.
- The authors ensure that all the references carefully and they are accurate in the text as well as in the list of references (and vice versa).
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution-NonCommercial 4.0 International that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author.